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TCR Antigen±Induced Cell Death
Occurs from a Late G1 Phase
Cell Cycle Check Point
peripheral T cells and suffer from an autoimmune-like
syndrome (Cohen and Eisenberg, 1991).
The involvement of cell cycle control in AID, first pro-
posed by Ashwell et al. (1987) in studies using T cell
hybridomas, suggested a G1 involvement. However,
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Departments of Pathology and Medicine subsequent studies of AID in peripheral T cells and
transformed T cell lines have produced conflicting re-Washington University School of Medicine
St. Louis, Missouri 63110 sults. Several groups have reported an S phase± specific
apoptosis based on experiments employing pharmaco-
logical cell cycle blockers to synchronize cells (Boehme
and Lenardo, 1993; Zhu and Anasetti, 1995; RadvanyiSummary
et al., 1996). In contrast, Fotedar et al. (1995) reported
a G2/M sensitivity of AID in T cell hybridomas. Cotter etDeletion of antigen-activated T cells after an immune
al. (1992) reported that stimulation of T cell hybridomasresponse and during peripheral negative selection
through the TCR resulted in a G1-specific apoptosis,after strong T cell receptor (TCR) engagement of cy-
while treatment of cells with pharmacological cell cyclecling T cells occurs by an apoptotic process termed
blockers that arrest cells in the G1, S, or G2 phases allTCR antigen-induced cell death (AID). By analyzing the
resulted in apoptosis. Given these conflicting reports,timing of death, cell cycle markers, BrdU-labeled S
the involvement of cell cycle control in initiating andphase cells,and phase-specific centrifugally elutriated
executing AID remains unclear.cultures from stimulated Jurkat T cells and peripheral
Control of cell cycle progression is a highly regulatedblood lymphocytes, we found that AID occurs from a
process involving both positive and negative regulatorylate G1 check point prior to activation of cyclin E:Cdk2
proteins that function at specific cell cycle check points,complexes. T cells stimulated to undergo AID can be
including the late G1 restriction point, the G1±S phaserescued by effecting an early G1 block by direct trans-
and G2±M phase transitions, and exit from mitosis (El-duction ofp16INK4a tumor suppressor protein or by inac-
ledge, 1996; Sherr, 1996). Positive regulators of cell cy-tivation of the retinoblastoma tumor suppressor pro-
cle progression include regulatory cyclin subunits thattein (pRb) by transduced HPV E7 protein. These results
bind and activate catalytic cyclin-dependent kinase (Cdk)suggest that AID occurs from a late G1 death check
subunits. In general, cyclins have cell cycle±dependentpoint in a pRb-dependent fashion.
expression patterns, such as induction of cyclin E at the
late G1 check point and cyclin A at the G1±S transition,Introduction
while Cdks are constitutively expressed (Sherr, 1996).
Negative regulators of cell cycle progression include theDuring thymocyte development, negative selection of
retinoblastoma tumor suppressor gene product (pRb)potentially self-reactive T cells occurs by an apoptotic
and cyclin-dependent kinase inhibitors, such as themechanism (Jenkinson et al.,1989; Shi et al., 1989; Smith
p16INK4a tumor suppressor gene and the p21CIP1/p27KIP1et al., 1989; Cohen and Duke, 1992). On mature resting
proteins (reviewed by Sherr, 1996). The late G1 restric-peripheral T cells, engagement of the T cell receptor
tion point is a key regulatory position in the cell cycle:(TCR) complex leads to interleukin-2 (IL-2) production
at this point the cell weighs the influence of externaland entry into the cell cycle (Kabelitz et al., 1993).
factors, such as ligands and growth factors, against theHowever, strong TCR stimulation of cycling T cells in
internal default cell cycle arrest machinery of proteinsthe periphery can also lead to negative selection by
such as pRb (Weinberg, 1995). Transition through theapoptosis, termed TCR antigen-induced cell death (AID)
restriction point appears to require inactivation of pRb(Jones et al., 1990; Rocha and von Boehmer, 1991; Ka-
by hyperphosphorylation by activated cyclin E:Cdk2belitz et al., 1993). AID is thought to control the expan-
complexes (Dou et al., 1993; Ezhevsky et al., 1997).sion of antigen-activated T cells after an immune re-
To understand the role, if any, of cell cycle control insponse and to delete self-reactive T cells in germinal
AID, we analyzed stimulated peripheral blood lympho-centers by peripheral negative selection (reviewed by
cytes (PBLs) and Jurkat T cells for cell cycle position,Green and Scott, 1994; Lenardo et al., 1995). AID occurs
Cdk activation, and phosphorylation status of pRb. Weby a Fas/Fas ligand±dependent (Ju et al., 1994; Dhein
report here a cell cycle requirement for AID that occurset al., 1995) apoptotic mechanism characterized by
at a late G1 check point. In addition, we find that thismembrane blebbing, activation of proteolytic caspases,
apoptotic program requires functional pRb for its exe-nuclear condensation, and DNA fragmentation (Okada
cution.et al., 1990; Shi et al., 1990). Indeed, lpr and gld mice
that harbor naturally occurring inactivating mutations of
Fas and Fas ligand, respectively, are unable to delete Results
AID Occurs in a Cell Cycle±Specific Fashion*These authors contributed equally to this study.
To address the question of a specific cell cycle sensitiv-²To whom correspondence should be addressed (dowdy@visar.
wustl.edu). ity to AID, we first chose to use Jurkat T cells because
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Figure 1. The Gradual Loss of TCR-Stimulated Cells over Time Correlates with the Length of the Cell Cycle
(A) Viability curve of control and PMA/ionomycin- or PDBu/ionomycin-stimulated asynchronous Jurkat T cell (left) and asynchronous normal
human peripheral blood lymphocyte (PBL, right) cultures after stimulation. The loss of viable cells is identical regardless of stimulus and is
90% complete with Jurkat cells by 24 hr and by 36 hr for PBLs as compared to control unstimulated cultures. Stimulation of Jurkat T cells
with PDBu/ionomycin for 2 hr followed by washing out of the stimulus from the culture results in loss of a portion of the cells, but the remaining
cells continue to proliferate with a slope equivalent to that of the control (left).
(B) Cell cycle profile of asynchronous Jurkat cultures after PMA/ionomycin stimulation. At various time points, control or stimulated cells were
harvested, fixed in EtOH, DNA stained with propidium iodide, and analyzed for cell cycle position by FACS. Cells in the stimulated cultures
are capable of cycling to G1 but fail to progress from G1 into S phase and instead proceed from G1 to the ,2N DNA population. The
unstimulated control culture profile remains relatively unchanged throughout the time course (t 5 0).
of their ability to cycle continuously without the addition media containing IL-2. Consistent with the results seen
in Jurkat T cells, PMA/ionomycin stimulation of asyn-of exogenous cytokines and their expression of a func-
tional TCR complex that upon strong TCR stimulation chronously cycling human PBLs also resulted in a grad-
ual decrease in cell number over 36 hr in culture com-induces AID (Green and Scott, 1994). The process of
AID can be mimicked in Jurkat cells by cross-linking pared to dividing control cells (Figure 1A, right).
To test whether stimulated asynchronous cells werethe TCR complex with anti-CD3 antibodies or lectins
(phytohemagglutinin) or by activating downstream sig- irreversibly committed to undergo AID or if resistant
phases existed in the cell cycle, Jurkat cells were stimu-naling molecules, such as protein kinase C and cal-
cineurin with phorbol esters (phorbol myristate acetate lated with the water-soluble reversible phorbol ester
PDBu in combination with ionomycin for 2 hr, washed,[PMA] or phorbol dibutyrate [PDBu]) in combination with
a calcium ionophore (ionomycin) (Wyllie et al., 1984; replated in fresh media, and analyzed for cell viability
at various time points (Figure 1A). During the 2 hr stimu-Smith et al., 1989; Shi et al., 1991). We stimulated Jurkat
T cells and/or PBLs and analyzed these populations lation, a limited numberof cells underwent AID;however,
after removal of the PDBu stimulus, the surviving cellsfor timing of death, cell cycle position, and molecular
markers of specific cell cycle phases. proliferated at a rate equivalent to that of the control
cultures. These results suggested that asynchronous TCultures of asynchronously cycling Jurkat T cells and
PBLs were stimulated with PMA/ionomycin and ana- cells are not universally susceptible to death signals,
but rather are sensitive to and resistant to death signalslyzed over a 24 hr time course for cell viability (Figure
1A). Viable cell number in control Jurkat cultures steadily at specific phases of the cell cycle.
We next investigated the cell cycle position of asyn-increased over the course of the experiment and nearly
doubled by 24 hr (Figure 1A, left). In stimulated cultures, chronous Jurkat cultures after stimulation over a 24 hr
time course. At various time points, control and PMA/however, the number of viable cells decreased over
time, and apoptosis was nearly complete by 24 hrs, ionomycin-stimulated cells were harvested, fixed in eth-
anol (EtOH), DNA stained with propidium iodide, andapproximately the length of theircell cycle.Similar kinet-
ics were observed with either PDBu/ionomycin treat- analyzed for cell cycle position by fluorescence-acti-
vated cell sorting (FACS) (Figure 1B). The cell cycle dis-ment or anti-CD3 TCR cross-linking treatment of Jurkat
T cells (Figure 1A and data not shown). The experiment tribution of control cells remained relatively constant
over the entire time course (Figure 1B, t 5 0, and datawas repeated using freshly isolated asynchronous hu-
man PBLs induced into cycle by culturing in conditioned not shown). However, by 18 hr, the percentage of cells
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in the G1 phase had increased in the stimulated cul-
tures and the S phase cell population was declining. By
26 hr, the majority of stimulated cells had undergone
apoptosis with no apparent reentry from the G1 into the
S phase. These results suggested that stimulated cells
were continuing to cycle from the S and G2/M phases
into G1 but not back into S phase and were therefore
preferentially undergoing AID from the G1 phase of the
cell cycle.
To examine whether stimulated cells were dying from
early or late G1 phase, the phosphorylation status of
pRb and the activation of Cdk2 were used as markers
of cell cycle position. The presence of fastest migrating,
active hypophosphorylated pRb on sodium dodecyl sul-
fate (SDS) polyacrylamide gel electrophoresis (PAGE) is
a hallmark of early G1 phase (DeCaprio et al., 1992;
Dowdy et al., 1997). Inactivation of pRb by hyperphos-
phorylation by activated cyclin E:Cdk2 complexes at the
late G1 restriction point leads to a diagnostically slower
migrating species on SDS-PAGE that persists through
the late G1, S, G2, and M phases (Mittnacht and Wein-
berg, 1991; DeCaprio et al., 1992; Dou et al., 1993).
Asynchronous JurkatT cells werestimulated with PDBu/
ionomycin as described above; whole-cell lysates were
prepared at various time points; and pRb phosphoryla-
tion status was analyzed by immunoblotting (Figure 2A). Figure 2. Gradual Loss of pRb Hyperphosphorylation, Accumula-
Asynchronous control cultures contained predominantly tion of Active Hypophosphorylated pRb, and Loss of Cdk2 Activity
in TCR-Stimulated Asynchronous Jurkat Cellsinactive hyperphosphorylated pRb over the entire time
(A) Whole-cell lysates were prepared at various time points fromcourse; however, the proportion of fastest migrating,
asynchronous control and PMA/ionomycin-stimulated Jurkat cul-active hypophosphorylated pRb steadily increased with
tures and immunoblotted with anti-pRb antibodies to analyze thetime in the stimulated cells. By 24 hr after stimulation,
pRb phosphorylation status at each time point. The fastest migrat-
pRb was almost exclusively in its active, hypophosphor- ing, active hypophosphorylated form of pRb (RBP) increases with
ylated form (lane 8). In addition, washout of PDBu/iono- time after stimulation.
mycin after 2 hr resulted in a temporary increase in (B) Asynchronous Jurkat cultures were stimulated with PDBu/iono-
mycin either for the entire 24 hr time course or for 2 hr followed byhypophosphorylated pRb at 2 and 5 hr, followed by a
removal of the stimulus by washing, replating, and treatment asreturn to predominantly more slowly migrating, inactive
above. pRb shifts from increasing accumulation of the fastest mi-hyperphosphorylated pRb (Figure 2B). The absence of
grating, active hypophosphorylated form (RBP) at 2 and 5 hr to the
hyperphosphorylated pRb in cells undergoing AID sug- slowest migrating, inactive hyperphosphorylated form (RBPP) after
gested a failure of these cells to progress through the withdrawal of stimulus.
late G1 restriction point. (C) Loss of Cdk2 activity with time after PDBu/ionomycin stimulation.
Cdk2 was immunoprecipitated from equal cell numbers at each timeTo examine further whether the apparent G1 apopto-
point from control and stimulated cultures and used for in vitrosis occurred at the late G1 restriction point, Cdk2 activity
kinase assays with baculovirus-produced pRb as substrate. Cdk2was analyzed. Whole-cell extracts were prepared from
activity remains constant in the control culture over the 24 hr time
control and stimulatedasynchronous Jurkat cellsat vari- course but decreases with time in the stimulated cultures as com-
ous time points over a 24 hr time course. Cdk2 was im- pared to the rabbit anti-mouse (RaM) negative control. Note nonspe-
munoprecipitated and in vitro kinase reactions were per- cific lower band present in all lanes. Mw, molecular weight stan-
dards; RBP, hypophosphorylated pRb; RBPP, hyperphosphorylatedformed using baculovirus-produced pRb as a substrate
forms of pRb.(Figure 2C). Control cultures maintained Cdk2 activity
throughout the time course; however, Cdk2 kinase activ-
ity steadily decreased in stimulated cultures, concomi-
cells were pulsed with a low concentration of BrdU fortant with loss of pRb hyperphosphorylation (Figure 2A).
30 min, plated in fresh media, and stimulated withThese results suggested that cyclin E:Cdk2 complexes
PDBu/ionomycin. Samples were isolated at various timewere not becoming activated in cells undergoing AID
points, fixed in acidic EtOH, treated with fluoresceinand further supported the notion that these cells fail to
isothiocyanate (FITC)±conjugated anti-BrdU antibodies,transit the late G1 restriction point.
the DNA counterstained with propidium iodide, and ana-
lyzed by FACS (Figures 3A and 3B). By 9 hr, both control
and stimulated BrdU-positive cells had begun to tra-S Phase Cells Cycle to G1 before Undergoing AID
To focus on phase-specific cellswithin an asynchronous verse from S phase, through G2/M, and into G1. Control
BrdU-positive cells had reentered S phase at 26 hr;population, S phase cells were labeled with the thy-
midine analog bromodeoxyuridine (BrdU), and these however, BrdU-positive stimulated cells progressed
from G1 into the ,2N DNA apoptotic compartment with-ªtaggedº cells were analyzed after stimulation in the
background of unlabeled, asynchronous cells. Jurkat T out reentry into S phase. The experiment was repeated
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Figure 3. Stimulated BrdU-Labeled Jurkat or PBL Cells Cycle from S Phase into G2/M and then G1 Prior to Death
(A and B) S phase cells from asynchronous control (A) or PDBu/ionomycin-stimulated (B) Jurkat cultures were BrdU pulse-labeled for 30 min
and analyzed over time by FACS after treatment with FITC-conjugated anti-BrdU antibodies and DNA staining with propidium iodide. Control
BrdU-positive, S phase cells are capable of cycling through G2/M and G1 and reenter the S phase at 18 and 26 hr. Stimulated BrdU-positive,
S phase cells cycle through G2/M into G1 but are unable to reenter S phase and instead enter the ,2N DNA apoptotic population.
(C and D) Cycling PBLs were BrdU labeled and stimulated as described above. Control BrdU-positive, S phase PBLs (C) are able to cycle
into G2/M and G1 and reenter S phase by 26 hr; however, stimulated BrdU-positive, S phase PBLs (D) progress through G2/M and into G1
but do not progress into S phase and instead enter the ,2N DNA apoptotic population.
using asynchronous PBLs that were BrdU pulse-labeled cells had begun to traverse from G2/M phase into G1
phase. By 8 hr, the majority of control cells had pro-for 60 min, stimulated with PDBu/ionomycin, and ana-
lyzed as described above (Figures 3C and 3D). The con- gressed into G1 and doubled in number (Figure 4A and
data not shown). Although the stimulated cells contin-trol BrdU-positive PBLs cycled from S phase through
G2/M into G1 and then progressed into S phase by 26 hr. ued to progress into G1 by 8 hr, the total cell number
had begun to drop to less than half of the control culture.In contrast, stimulated BrdU-positive PBLs progressed
into G1, but then appeared in the ,2N DNA compart- Twelve hours after replating, control cells started to en-
ter S phase; however, stimulated cells failed to enter Sment without reentry into S phase. These results further
support a G1 phase dependency for AID, in that even phase even 18 hr after replating, and their numbers con-
tinued to decrease dramatically (Figure 4B). These re-S phase stimulated cells traverse through G2/M and
then into G1 before undergoing apoptosis. sults demonstrated that stimulated, synchronized G2/M
phase T cells must cycle into the G1 phase of the cell
cycle prior to undergoing AID. Consistent with this ob-Synchronized T Cells Undergo AID
from a Late G1 Check Point servation, replating and stimulation of elutriated early
G1 phase cells also undergo late G1 phase±specificTo investigate further the G1 requirement for AID, we
sought to isolate synchronized populations of T cells. apoptosis within 7±9 hr, failing to enter S phase (data
not shown).Previous investigators had used cell cycle blockers to
synchronize T cells and reported varied results, perhaps To determine whether stimulated cells were pro-
gressing past the restriction point into late G1, replatedbecause of toxicity introduced by these pharmacologi-
cal agents. Therefore, we used the biologically noninva- elutriated G2/M phase cells were analyzed for Cdk2
activity and cyclin E expression. Whole-cell extractssive method of centrifugal elutriation (Dowdy et al., 1997)
to isolate cell cycle phase±specific cells. Jurkat T cells were prepared from parallel cultures of control and
PDBu/ionomycin-stimulated replated elutriated G2/M(5 3 108) were elutriated in media plus serum at 348C.
G2/M fractions were isolated, cells replated with or with- phase cells as described above. Cdk2 was immunopre-
cipitated from these lysates after normalization for pro-out PDBu/ionomycin stimulation, and followed for cell
cycle position by DNA staining with propidium iodide tein concentration, and in vitro kinase assays were per-
formed using histone H1 as a substrate (Figure5A). Cdk2and analyzed by FACS at various time points (Figure 4).
Two hours after replating, both control and stimulated activity from control cultures was detected 6 hr after
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Figure 4. Late G1 Dependency for AID from Elutriated G2/M Cells
(A) Cell cycle progression of control, unstimulated elutriated G2/M Jurkat cells over time. Cells were replated and harvested, stained with
propidium iodide, and analyzed for cell cycle position by FACS at the indicated time points. Control cells initially enter G1 after 2 hr, double
in cell number by 8 hr, and enter S phase by 18 hr.
(B) Parallel cultures of the elutriated G2/M Jurkat fractions were stimulated with PDBu/ionomycin and analyzed as in (A). Numbers of stimulated
cells increase initially and then decline with time after stimulation. At 8 hr, no substantial increase in the G1 population is observed and no
S phase entry is seen even after 18 hr while cell numbers continue to decrease dramatically.
replating and reached maximum activity by 16 hr (lanes 5 into target cells, eliciting an early G1 arrest, sequestra-
tion of Cdk6, and loss of pRb hypophosphorylation (Ez-and 6).However, only background levels of Cdk2 activity
were detected in replated stimulated cultures over the hevsky et al., 1997).
To sequester pRb, we cloned wild-type and non±pRb-entire time course (lanes 8±11). Immunoblot analysis of
cyclin E, the Cdk2 cyclin partner in late G1, showed an binding mutant HPV E7 cDNAs into the pTAT bacterial
expression plasmid, and recombinant proteins were pu-induction of cyclin E protein in control cultures, while no
induction of cyclin E protein was detected in stimulated rified from bacterial lysates. Purified TAT-E7 fusion pro-
teins were analyzed for their ability to transduce intocultures (Figure 5B, lane 3 vs. lane 7). Examination of
cyclin E mRNA levels by reverse transcriptase polymer-
ase chain reaction also demonstrated a failure of stimu-
lated cells to induce cyclin E mRNA (data not shown).
Thus, the absence of Cdk2 activity in stimulated cultures
was due in part to a lack of cyclin E induction and is
consistent with a failure of these stimulated cells to
transit the late G1 restriction point.
AID Requires a Late G1 Check Point
pRb is a negative regulator of the late G1 restriction
point (Weinberg, 1995). To determine whether pRb was
involved in mediating AID from this check point, we
sought to rescue cells from AID by inactivating pRb
by sequestration with human papillomavirus (HPV) E7
protein and by effecting an early G1 cell cycle arrest by
sequestration of Cdk4/6 with the p16INK4a tumor suppres-
sor protein (Chellappan et al., 1992; Dyson et al., 1992;
Pagano et al., 1992; Munger and Phelps, 1993; Serrano
et al., 1993; Xiong et al., 1993; Sherr and Roberts, 1995).
Figure 5. Loss of Cdk2 Activity and Cyclin E Expression in Stimu-To do so, we further developed the method of transduc-
lated Elutriated G2/M Phase Cells Undergoing AID
ing full-length fusion proteins directly into more than
(A) Immunoprecipitated (IP) Cdk2 at various time points from elutri-99%of target cells (Ezhevsky et al., 1997; Vocero-Akbani
ated control and PDBu/ionomycin-stimulated replated G2/M Jurkat
et al., submitted). In brief, bacterially expressed recom- cells was used for in vitro kinase assays with histone H1 as sub-
binant in-frame fusion proteins are generated with a strate. Cdk2 activity is initially detected in control cells at 6 hr,
peaking at 16 hr after replating. In contrast, Cdk2 is not inducedsmall N-terminal protein transduction domain from hu-
over the 22 hr time course in the stimulated cells. RaM, rabbit anti-man immunodeficiency virus TAT protein. TAT fusion
mouse.proteins rapidly enter cells in a concentration-depen-
(B) Whole-cell lysates were prepared from treated cells as abovedent first-order equilibrium reaction, reaching maximum
and immunoblotted with anti-cyclin E antibodies. Cyclin E is induced
intracellular concentrations in less than 30 minutes. Pre- by 18 hr in control cultures;however, cyclinE protein levels decrease
viously, we have successfully used this method to trans- to almost undetectable levels by 18 hr in stimulated cultures. H1,
histone H1; cyc E, cyclin E.duce bothTAT-p16 wild-type and mutant fusion proteins
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Figure 7. Rescue of AID by Direct Transduction of TAT-E7 and TAT-
p16 Protein
Purified TAT-E7 and TAT-p16 wild-type and mutant proteins were
transduced into PDBu/ionomycin-stimulated elutriated G1 Jurkat T
cells at 50 or 200 nM final concentration and then assayed for cell
viability 9 hr after stimulation. Both TAT-E7 and TAT-p16 wild-type
proteins rescued cells from AID, 88% and 76% at 200 nM, respec-
tively. TAT-E7 mutantprotein retains a low affinity for pRb and shows
a weak level of protection compared to TAT-E7 wild-type protein.
Cell viability was determined by trypan blue dye exclusion. All exper-
iments were performed in triplicate, and error bars indicate standard
deviation.
immunoprecipitation with anti-pRb antibodies and reso-
lution on SDS-PAGE (Figure 6B). TAT-E7 wild-type pro-Figure 6. Characterization of TAT-E7 Wild-Type and Mutant Fusion
tein retained the ability to bind pRb in vivo with highProteins
affinity, while TAT-E7 mutant protein had a low but de-(A) Purified TAT-E7 proteins transduce into Jurkat cells. Affinity col-
umn±purified TAT-E7 wild-type and mutant proteins were FITC-con- tectable ability to bind pRb (lane 1 vs. 2). Thus, TAT-E7
jugated, purified by gel filtration, added to Jurkat cultures for 30 wild-type and mutant fusion proteins are capable of
min, and analyzed by FACS. Both TAT-E7 wild-type and mutant transducing into more than 99% target cells, and TAT-
proteins transduce into more than 99% of the cells and retain a
E7 wild-type protein retains the previously identifiedtight intracellular concentration, as evidenced by the constant peak
property of sequestering pRb with high affinity.width between control and transduced cellular populations.
Finally, we assayed the ability of both TAT-p16 and(B) TAT-E7 wild-type protein associates with pRb in vivo. Cells were
transduced with either TAT-E7 wild-type or mutant protein and la- TAT-E7 fusion proteins to rescue T cells from AID. Cen-
beled with [35S]methionine. Whole-cell lysates were prepared and trifugally elutriated early G1 Jurkat T cells were replated,
treated with anti-E7 antibodies, followed by anti-pRb secondary incubated for 1 hr with purified TAT-p16 or TAT-E7 wild-
immunoprecipitations (IP). TAT-E7 wild-type protein binds pRb with
type or mutant fusion proteins at 50 nM or 200 nM,high affinity while TAT-E7 mutant protein binds pRb with reduced,
stimulated to undergo AID with PDBu/ionomycin, andlow affinity.
analyzed for cell viability at various time points (Figure
7). Analysis of stimulated cells 9 hr after stimulation
demonstrated a 40% viability of control cells comparedtarget cells by adding FITC-conjugated TAT-E7 pro-
teins to the culture media of Jurkat T cells and analyz- to unstimulated cells. However, treatment of stimulated
cells with TAT-p16 wild-type protein, but not mutanting by FACS (Figure 6A). Both TAT-E7 wild-type and
mutant proteins efficiently transduced into more than protein, resulted in a marked rescue from AID, with 76%
viability at 200 nM TAT-p16. Treatment of stimulated99% of target cells and reached a maximum intracellular
concentration within 30 min of addition. To ascertain cells with TAT-E7 wild-type protein also resulted in a
dramatic rescue from AID, with 88% viability at 200 nMwhether TAT-E7 protein retained the ability to bind pRb
in vivo, TAT-E7 wild-type and mutant proteins were TAT-E7. The TAT-E7 mutant protein elicited a slight de-
gree of rescue from AID, 55% viability at 200 nM, proba-transduced into cells during concomitant [35S]methio-
nine labeling of cellular proteins. Whole-cell lysates were bly because of its retained low-affinity ability to bind
pRb (see Figure 6B, lane 2). Thus, either arresting cellsprepared and primary immunoprecipitation with anti-
E7 antibodies was performed, followed by secondary in early G1 prior to the restriction point by inactivating
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Cdk4/6 with TAT-p16 protein or by sequestering pRb incorporation) and strong TCR stimulation would result
in a nonphysiological S phase death (Boehme and Le-with TAT-E7 protein protects from the cell from AID.
nardo, 1993). Fotedar etal. (1995) reported a G2/M sensi-
tivity to AID; however, data within this report demon-
Discussion strate that S phase±synchronized T cell hybridomas
stimulated by anti-CD3 cross-linking cycle through G2/M
While the proximal signaling mediators of AID are be- into G1 prior to undergoing apoptosis. In addition, this
coming better characterized, the specific role of cell group's finding that antisense oligonucleotides to cyclin
cycle control in this process has remained unclear. Evi- B1 were protective is consistent with our observations
dence for both an S phase and a G2/M phase depen- of a G1 phase susceptibility by inhibiting cell cycle pro-
dency have been reported in distinct systems. However, gression to the restriction point. Thus, a late G1 sensitiv-
the use of T cell hybridomas and/or pharmacological ity to AID is consistent with observations reported in
cell cycle inhibitors may prevent these results from full earlier studies.
generality; the control of T cells may be distinct. The results presented here implicate cell cycle regula-
To solve this paradox while avoiding the introduction tion as integral in deciding cell fates in response to
of potential artifacts into the system, we investigated stimuli such as peripheral negative selection and rees-
the role of cell cycle control in AID using markers of cell tablishment of the immune repertoire after an immune
cycle progression, BrdU labeling of S phase cells in response. The late G1 restriction point has previously
an asynchronous population, observation of replated been defined by an extracellular growth factor depen-
centrifugally elutriated synchronized cells, and rescue dency to transit this position, after which the cell moves
by direct protein transduction of sequestering proteins into growth factor±independent positions of the cell cy-
into synchronized cells. Based on the passage of stimu- cle (Pardee, 1974; Weinberg, 1995; Sherr, 1996). Thus,
lated BrdU-labeled Jurkat and PBL cells from S phase at the restriction point, the cell weighs the extracellular
into G2/M then into G1 prior to their appearance in the environment against the intracellular environment. An
,2N DNA apoptotic compartment as well as the pas- attractive hypothesis is that components of the cell cy-
sage of stimulated G2/M phase±elutriated cells into G1 cle machinery negatively regulate the activation of cas-
before they became apoptotic, we conclude that AID pases and their execution of the apoptotic program. The
occurs from G1. In addition, the presence of active, apoptotic machinery appears to be present in cycling
hypophosphorylated pRb in apoptotic cells and the abil- cells but inactive until the cell transits to the restriction
ity to rescue committed stimulated G1 cells from AID point, where it can be activated upon appropriate stimu-
by inactivation of pRb via TAT-E7 protein supports the lus. In effect, the restriction point functions as a death
notion that AID occurs at the late G1 check point. These check point. If conditions are appropriate for cell prolif-
results also demonstrate the requirement for active, hy- eration, the apoptotic effector proteins will continue to
pophosphorylated pRb to allow activation of the down- be negatively regulated; however, if conditions necessi-
stream apoptotic machinery and to suggest a new role tate deletion of the cell, the apoptotic program is acti-
for pRb as an active participant in executing apoptosis. vated. Thus, inactivation of pRb in oncogenesis would
Moreover, the inability of stimulated cells to induce contribute to a loss of this apoptotic regulation and
cyclin E or activate Cdk2 during AID further supports the thereby aid in the transformation process.
notion that the decision to undergo AID is preferentially The late G1 death check point requirement for AID
made at this late G1 check point. may represent a broader requirement of receptor-medi-
Our conclusions differ from earlier reports proposing ated apoptosis. For instance, in response to stimulation,
an S or G2/M phase dependency for AID; however, given synchronized B cell lymphomas undergo G1 phase±
recent advances in understanding cell cycle progres- specific AID that is accompanied by an induction of
sion, reevaluation of these earlier reports could also p27KIP1 cyclin-dependent kinase inhibitor protein levels;
support a G1 dependency. For instance, Boehme and a decrease in Cdk2 activity; and the presence of active,
Lenardo (1993) reported an S phase±specific AID mech- hypophosphorylated pRb (Scott et al., 1987; Ezhevsky
anism based on experiments using pharmacological cell et al., 1996). In addition, postmitotic sympathetic neu-
cycle blockers where G1-arrested cells were protected rons and neuroblastoma cells deprived of nerve growth
from AID. This is consistent with our observations that factor undergo apoptosis that is accompanied by a dra-
blocking the cell cycle prior to the restriction point is matic increase in cyclin D1 levels with subsequent acti-
protective. This group also observed an S phase sensi- vation of Cdk4 and can be rescued by transfection of
tivity; however, toxicity associated with the blocking p16INK4a (Freeman et al., 1994; Kranenburg et al., 1996),
agents used in the absence of TCR stimulation was suggesting that cells transit from an apoptotic-resistant
noted by the authors. Indeed, we observed that labeling G0 phase into an apoptotic sensitive G1-like phase.
S phase cells with standard experimental concentra- Taken together with data presented here, these obser-
tions of BrdU, a DNA analog and potential activator of vations suggest that receptor-mediated activation of
DNA damage±dependent apoptosis, results in S phase apoptosis occurs from the late G1 death check point.
death upon TCR stimulation; however, stimulation of The cell has organized an elaborate system to integrate
BrdU-labeled S phase cells using 2000-fold less concen- stimulus from the extracellular environment with the in-
trated BrdU (as in the present study) allows passage of tracellular negative regulation imposed by pRb at the
these labeled stimulated cells through the cell cycle restriction/death check point. Thus, understanding the
into G1 before apoptotic induction. Thus, the competing cell cycle regulatory mechanisms involved in receptor-
mediated apoptosis may allow further insights into howsignals of DNA damage (caused by high levels of BrdU
Immunity
64
rabbit anti-pRb antibodies (Santa Cruz) plus fresh protein A beadsalteration of these pathways leads to autoimmunity, ma-
for 4 hr at 48C. Immune complexes were washed three times in ELB,lignancy, and developmental abnormalities.
resolved on SDS-PAGE, and analyzed by phosphorimager analysis.
Experimental Procedures BrdU Labeling
Asynchronous Jurkat and PBL cultures were pulse labeled for 30
Cell Culture and 60 min, respectively, with 5 nM BrdU (Amersham), washed with
Jurkat leukemic T cells were obtained from American Type Culture PBS, replated at z1 3 106 cells/ml, and stimulated with PDBu/
Collection andmaintained in RPMI-1640 (Gibco±BRL) media supple- ionomycin. Because of nonspecific death associated with the rec-
mented with 5% heat-inactivated fetal bovine serum (FBS) plus ommended concentrations of BrdU in published protocols, we di-
penicillin and streptomycin. For stimulation, cells were resuspended luted the BrdU 1:2000 prior to use. BrdU-labeled cells were fixed in
in fresh media at approximately 1 3 106 cells/ml, and 190 nM PDBu acidic 70% ethanol (pH 2.0) at 2208C for 30 min, washed, incubated
or 10 nM PMA plus 2 mM ionomycin (Calbiochem) was added to in 1 N HCl/0.5% Nonidet P-40 for 45 min at RT, pelleted, resus-
cultures. For washout experiments, cells were incubated with PDBu/ pended in 0.1 M Na2B4O7, and incubated for 5 min at RT, and resus-
ionomycin for 2 hr, washed with phosphate-buffered saline (PBS), pended in PBS/1% bovine serum albumin (BSA)/0.5% Tween-20.
and replated in fresh media. For anti-CD3 cross-linking, 96-well FITC-conjugated anti-BrdU antibodies (CalTag) were added and in-
plates were coated with 64.1 anti-CD3 monoclonal antibody (400 cubated for 30 min at RT. Cells were washed and resuspended in
ng/well) overnight at room temperature (RT) and washed with PBS PBS/0.1% FBS/propidium iodide (10 mg/ml), and analyzed by FACS
prior to the addition of cells. PBLs were isolated from a leukocyte by gating on FITC-positive cells.
pack essentially as described by Amoroso and Lipsky (1990) and
grown in a 1:1 mix of RPMI and filtered conditioned media from Centrifugal Elutriations
Jurkat cells plus 20% FBS. For rescue experiments, TAT fusion Elutriations were performed as described (Dowdy et al., 1997). In
proteins (see below) were added to cell cultures 1 hr prior to PDBu/ brief, z5 3 108 Jurkat cells were injected into a Beckman JE-6B
ionomycin stimulation. Cell viability was determined by trypan blue elutriation rotor. Cells were elutriated in RPMI media plus 3% FBS,
exclusion. Percentage viability was determined by the number of penicillin, and streptomycin, at 348C, at a constant rotor speed (2100
viable cells in TAT-treated, stimulated cultures divided by the viable rpm) and increasing (1 ml/min) flow rates from 9 to 28 ml/min. Frac-
cell number in TAT-treated, unstimulated cultures. All experiments tions (100 ml) were collected and analyzed by FACS for cell cycle
were done in triplicate. For DNA profile analyses, cells were washed position and the appropriate fractions used. Elutriated cells were
in PBS, fixed in 70% ethanol at 2208C or 0.5% Nonidet P-40 solution pelleted, replated in fresh RPMI with 5% FBS, at z1 3 106 cells/
in PBS supplemented with aprotinin (1 mg/ml), leupeptin (1 mg/ml), ml for G2/M cells experiments and z1.7 3 106 cells/ml for rescue
and phenylmethylsulfonyl fluoride (PMSF) (50 mg/ml), washed, and experiments of G1 cells.
resuspended in PBS/0.1% FBS/RNAse A (1 mg/ml)/propidium iodide
(10 mg/ml) for 20 min prior to analysis on FACScan (Becton Dickin-
TAT Fusion Protein Purificationson). Ten thousand gated events were collected per sample.
Wild-type and mutant E7 cDNAs were cloned into the NcoI±EcoRI
site of pTAT vector (Ezhevsky et al., 1997; Vocero-Akbani et al.,
Immunoblotting, Immunoprecipitations, and Kinase Assays submitted). The pTAT-E7 plasmids were transformed into BL-21(DE-
Whole-cell lysates were prepared as described (Dowdy et al., 1993) 3)LysS cells (Novagen) and high-expressing clones isolated. TAT-
by the addition of 1 ml of ELB (50 mM HEPES [pH 7.2], 250 mM E7 and TAT-p16 fusion proteins were purified by sonication of BL-
NaCl, 2 mM EDTA, 0.1% Nonidet P-40, 1 mM dithiothreitol, 1 mg/ml 21 cells from a 1 liter culture in 10 ml of 8 M urea, 20 mM HEPES
aprotinin, 1 mg/ml leupeptin, and 50 mg/ml PMSF). For immunoblot (pH 7.2), 100 mM NaCl, 1 mg/ml aprotinin, 1 mg/ml leupeptin, and
analysis, equal amounts of protein (quantitated by Biorad assay) of 50 mg/ml PMSF. Lysates were clarified by centrifugation and the
each sample were loaded on a 6% (pRb) or 12.5% (cyclin E) SDS- supernatant loadedonto a 5 ml Ni-NTA column (Qiagen) in the above
PAGE gel, transferred to nitrocellulose filters, blocked in 5% nonfat buffer containing 20 mM imidazole. TAT fusion proteins were eluted
milk/PBS/0.2% Tween for 30 min, and then incubated for 4 hr with by increasing imidazole concentration followed by either dialysis
anti-pRb (PharMingen) or anti-cyclin E (PharMingen) antibodies. The against 20 mM HEPES (pH 7.2), 137 mM NaCl overnight at 48C or
filters were washed three times in PBS/0.2% Tween, probed with ionic exchange chromatography on an FPLC column (Pharmacia)
secondary antibodies coupled to horseradish peroxidase (Jackson followed by a desalting column. Purified TAT fusion protein concen-
Laboratories) for 1 hr, washed three times, and developed with the trations were determined by Coomassie Blue staining of SDS-PAGE
addition of enhanced chemiluminescence reagent, and exposed to compared to BSA standards. FITC-labeled TAT fusion proteins were
film (Kodak). For anti-Cdk2 immunoprecipitations, cellular lysates generated by fluorescein labeling (Pierce), followed by gel purifica-
were precleared with killed Staphylococcus aureus cells (Zymed) tion on a S-12 gel filtration column attached to an FPLC. FITC-
and 10 ml rabbit anti-Cdk2 (Santa Cruz) added for 4 hr. Immune conjugated TAT-E7 proteins were added to Jurkat T cells and ana-
complexes were collected on protein A Sepharose (Pharmacia), lyzed by FACS.
washed three times with 1 ml ELB, and finally washed with kinase
buffer (50 mM HEPES [pH 7.0], 10 mM MgCl2, 1 mM dithiothreitol, Acknowledgments
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